Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells

International Journal of Pharmaceutics

Volumn 411, Issue 1-2, 2011, Pages 136-141

  Maupas, Caroline ^a   Moulari, Brice ^a   Béduneau, Arnaud ^a   Lamprecht, Alf ^a,b,c   Pellequer, Yann ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY OF BONN   (Germany)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

Cutaneous formulation; Keratinocytes; Lipid nanocapsules; Surfactant; Toxicity

Indexed keywords

CREMOPHOR; IBUPROFEN; LIPID; LIPID NANOCAPSULE; NANOCAPSULE; NONIONIC SURFACTANT; POLYOXYL 40 HYDROGENATED CASTOR OIL; POLYSORBATE 20; POLYSORBATE 80; SOLUTOL HS 15; TOCOFERSOLAN; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; DRUG STABILITY; FEASIBILITY STUDY; IC 50; IN VITRO STUDY; KERATINOCYTE; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SURFACE TENSION; SYNTHESIS; TOXICITY TESTING;

CELL LINE; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; KERATINOCYTES; LIPIDS; NANOCAPSULES; PHARMACEUTICAL PREPARATIONS; POLYETHYLENE GLYCOLS; SKIN; SURFACE-ACTIVE AGENTS; VITAMIN E;

EID: 79955960577     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.056     Document Type: Article

References (25)

1. Abdel-Mottaleb, M.M., Neumann, D., Lamprecht, A., 2010. In vitro drug release mechanism from lipid nanocapsules (LNC). Int. J. Pharm. 390, 208-213.
2. Abdel-Mottaleb, M.M., Lamprecht, A., 2011. Standardized in-vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I. Drug Dev. Ind. Pharm. 37, 178-184.
3. Chen, D., Yang, T., Lu, W., Zhang, Q., 2001. In vitro and in vivo study of two types of long circulating solid lipid nanoparticles containing paclitaxel. Chem. Pharm. Bull. 49, 1444-1449.
4. Dillen, K., Vandervoort, J., Van den Mooter, G., Verheyden, L., Ludwig, A., 2004. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int. J. Pharm. 275, 171-187.
5. Duclairoir, C., Orecchioni, A.M., Depraetere, P., Osterstock, F., Nakache, E., 2003. Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs. Int. J. Pharm. 253, 133-144.
6. Ernst, R., Arditti, J., 1980. Biological effects of surfactants. IV. Effects of non-ionics and amphoterics on HeLa cells. Toxicology 15, 233-242.
7. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2002. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875-880.
8. Husseini, G.A., Pitt, W.G., 2008. Micelles and nanoparticles for ultrasonic drug delivery. Adv. Drug Deliv. Rev. 60, 1137-1152.
9. Joshi, M., Patravale, V., 2008. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm. 346, 124-132.
10. Lamprecht, A., Benoit, J.P., 2006. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J. Control. Release 112, 208-213.
11. Lamprecht, A., Bouligand, Y., Benoit, J.P., 2002. New lipid nanocapsules exhibit sustained release properties for amiodarone. J. Control. Release 84, 59-68. (Pubitemid 35223414)
12. Lamprecht, A., Saumet, J.L., Roux, J., Benoit, J.P., 2004. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int. J. Pharm. 278, 407-414.
13. Lboutounne, H., Chaulet, J.F., Ploton, C., Falson, F., Pirot, F., 2002. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(ε-caprolactone) nanocapsule encapsulated form and as a digluconate. J. Control. Release 82, 319-334. (Pubitemid 34880187)
14. Lu, W., He, L.C., Wang, C.H., Li, Y.H., Zhang, S.Q., 2008. The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice. Int. J. Biol. Macromol. 43, 320-324.
15. Luengo, J., Weiss, B., Schneider, M., Ehlers, A., Stracke, F., Konig, K., Kostka, K.H., Lehr, C.M., Schaefer, U.F., 2006. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19, 190-197.
16. Miyazaki, S., Takahashi, A., Kubo, W., Bachynsky, J., Löbenberg, R., 2003. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J. Pharm. Pharmaceut. Sci. 6, 238-245.
17. Müller, R.H., Radtke, M., Wissing, S.A., 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54, 131-155.
18. Otberg, N., Richter, H., Schaefer, H., Blume-Peytavi, U., Sterry, W., Lademann, J., 2004. Variations of hair follicle size and distribution in different body sites. J. Invest. Dermatol. 122, 14-19.
19. Partearroyo, M.A., Ostolaza, H., Goni, F.M., Barbera-Guillem, E., 1990. Surfactant-induced cell toxicity and cell lysis: a study using B16 melanoma cells. Biochem. Pharmacol. 40, 1323-1328.
20. Peltier, S., Oger, J.M., Lagarce, F., Couet, W., Benoit, J.P., 2006. Enhanced oral paclitaxel bioavailability after administration of paclitaxel loaded lipid nanocapsules. Pharm. Res. 23, 1243-1250.
21. Roger, E., Lagarce, F., Benoit, J.P., 2009. The gastrointestinal stability of lipid nanocapsules. Int. J. Pharm. 379, 260-265.
22. Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H.C., Kramer, K.D., Schaefer-Korting, M., 2004. Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 97, 493-502. (Pubitemid 38802951)
23. Woodcock, D.M., Linsenmeyer, M.E., Ghojnowski, G., Kriegler, A.B., Nink, V., Webster, L.K., Sawyer, W.H., 1992. Reversal multidrug resistance by surfactants. Br. J. Cancer 66, 62-68.
24. Wu, X., Price, G.J., Guy, R.H., 2009. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol. Pharm. 6, 1441-1448.
25. Zara, G., Cavalli, R., Fundaro, A., Bargoni, A., Caputo, O., Gasco, M., 1999. Pharmacokinetics of doxorubicin incorporated in solid lipid nanoparticles (SLN). Pharm. Res. 44, 281-289.